title: The serotonin and the bone assessment.
abstract: BACKGROUND
  Lately, the in vitro and in vivo studies on serotonin metabolism pointed their influence in bone health. In addition, there are no particular recommendations in performing the serum serotonin assessment in order to evaluate the skeletal status. Aim. We aimed to correlate the bone turnover markers and lumbar bone mineral density (BMD) with serotonin.
  
  
  METHODS
  There is a cross-sectional study in Caucasian postmenopausal women. They were not diagnosed with carcinoid syndrome, or bone anomalies, and received no treatment (including antiresorptives). We performed the bone formation markers: serum alkaline phosphatase (AP), serum osteocalcin (OC), and the bone resorption marker: serum CrossLaps (CL). Serum serotonin (high-pressure liquid chromatography), as well as central DXA (GE Prodigy) were assessed.
  
  
  RESULTS
  191 women of 57.1 years mean age were grouped according to DXA (WHO criteria). The linear regression analysis between serum serotonin and CL was not statistically significant (SS), between serotonin and OC was SS in the newly diagnosed osteoporosis group (N=40, r=0.4, p=0.03), between serotonin and AP we found SS in osteopenia group (N=88, r=0.24, p=0.03), with no changes when adjusting for age and BMI. The partial correlation between serotonin and BMD was not SS.
  
  
  CONCLUSIONS
  The study raises the question of serotonin as a bone metabolism marker seeing that the results were not consistent. The main limit of our study is that we did not analyze the possible use of antidepressants by these women. Overall, this is a pilot study in clinical practice in which few reports have been published yet, but still necessary because the use of serum serotonin in current skeletal evaluation is still unclear.
authors.affiliation: Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. carsote_m@hotmail.com
authors.forename: M
authors.initials: M
authors.lastname: Carsote
authors.forename: V
authors.initials: V
authors.lastname: Radoi
authors.forename: A
authors.initials: A
authors.lastname: Geleriu
authors.forename: A
authors.initials: A
authors.lastname: Mihai
authors.forename: D
authors.initials: D
authors.lastname: Ferechide
authors.forename: D
authors.initials: D
authors.lastname: Opris
authors.forename: D
authors.initials: D
authors.lastname: Paun
authors.forename: C
authors.initials: C
authors.lastname: Poiana
mesh_terms: D015502:Absorptiometry, Photon; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D015519:Bone Density / Q000502:physiology*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D015675:Osteocalcin / Q000378:metabolism; D012701:Serotonin / Q000097:blood*
chemical_list: D015675:Osteocalcin; D012701:Serotonin; D000469:Alkaline Phosphatase
keywords: Alkaline Phosphatase; CrossLaps; Osteocalcin; osteoporosis; serotonin
references.citation: Biol Psychiatry. 2009 Sep 1;66(5):423-32
references.pmid: 19446797
references.citation: Eur Psychiatry. 2012 Apr;27(3):156-69
references.pmid: 21295451
references.citation: Biol Psychiatry. 2013 Jul 1;74(1):32-9
references.pmid: 23260229
references.citation: J Psychiatr Res. 2011 Oct;45(10):1316-20
references.pmid: 21531430
references.citation: J Clin Psychopharmacol. 2008 Aug;28(4):411-7
references.pmid: 18626268
references.citation: Biochem Biophys Res Commun. 2005 Sep 9;334(4):1165-71
references.pmid: 16038876
references.citation: Mol Cell Endocrinol. 2013 Jan 5;365(1):25-35
references.pmid: 22975078
references.citation: Mol Cell Endocrinol. 2012 Mar 5;350(1):136-44
references.pmid: 22209745
references.citation: Bone. 2012 Jun;50(6):1260-5
references.pmid: 22425693
references.citation: Clin Chim Acta. 2010 Feb;411(3-4):167-71
references.pmid: 19891962
references.citation: Cell. 2008 Nov 28;135(5):795-6
references.pmid: 19041744
references.citation: Diabetes Res Clin Pract. 2011 Nov;94(2):167-71
references.pmid: 21775011
references.citation: N Engl J Med. 2009 Mar 5;360(10):957-9
references.pmid: 19264685
references.citation: Bone. 2012 Sep;51(3):606-13
references.pmid: 22659406
references.citation: Psychiatry Res. 1996 Nov 15;65(2):79-95
references.pmid: 9122289
references.citation: Cell. 2009 Sep 4;138(5):976-89
references.pmid: 19737523
references.citation: Bone. 2010 Jan;46(1):13-7
references.pmid: 19664737
references.citation: Psychiatry Res. 2012 Dec 30;200(2-3):343-8
references.pmid: 22921508
references.citation: Toxicol Appl Pharmacol. 2007 May 15;221(1):111-8
references.pmid: 17383703